China Antisense and RNAi Therapeutics Market Report & Forecast 2021-2027

Publisher Name :
Date: 03-Nov-2021
No. of pages: 93
Inquire Before Buying

China Antisense and RNAi Therapeutics Market, By Type, 2016-2021, 2022-2027 ($ Millions)

China Antisense and RNAi Therapeutics Market Segment Percentages, By Type, 2020 (%)

- RNA Interference

- Antisense RNA

China Antisense and RNAi Therapeutics Market, By Application, 2016-2021, 2022-2027 ($ Millions)

China Antisense and RNAi Therapeutics Market Segment Percentages, By Application, 2020 (%)

- Hospital

- Clinic

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Antisense and RNAi Therapeutics revenues in China market, 2016-2021 (Estimated), ($ millions)

Key companies Antisense and RNAi Therapeutics revenues share in China market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- Tekmira Pharmaceuticals

- Arbutus Biopharma

- Alnylam Pharmaceuticals

- Antisense Therapeutics

- Silence Therapeutics

- Isis Pharmaceuticals

- Sirnaomics

- Santaris

- Roche

China Antisense and RNAi Therapeutics Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Antisense and RNAi Therapeutics Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Antisense and RNAi Therapeutics Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Antisense and RNAi Therapeutics Overall Market Size
2.1 China Antisense and RNAi Therapeutics Market Size: 2021 VS 2027
2.2 China Antisense and RNAi Therapeutics Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Antisense and RNAi Therapeutics Players in China Market
3.2 Top China Antisense and RNAi Therapeutics Companies Ranked by Revenue
3.3 China Antisense and RNAi Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Antisense and RNAi Therapeutics Companies in China Market, by Revenue in 2020
3.5 Companies Antisense and RNAi Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Antisense and RNAi Therapeutics Players in China Market
3.6.1 List of Tier 1 Antisense and RNAi Therapeutics Companies in China
3.6.2 List of Tier 2 and Tier 3 Antisense and RNAi Therapeutics Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Antisense and RNAi Therapeutics Market Size Markets, 2021 & 2027
4.1.2 RNA Interference
4.1.3 Antisense RNA
4.2 By Type - China Antisense and RNAi Therapeutics Revenue & Forecasts
4.2.1 By Type - China Antisense and RNAi Therapeutics Revenue, 2016-2021
4.2.2 By Type - China Antisense and RNAi Therapeutics Revenue, 2022-2027
4.2.3 By Type - China Antisense and RNAi Therapeutics Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Antisense and RNAi Therapeutics Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application - China Antisense and RNAi Therapeutics Revenue & Forecasts
5.2.1 By Application - China Antisense and RNAi Therapeutics Revenue, 2016-2021
5.2.2 By Application - China Antisense and RNAi Therapeutics Revenue, 2022-2027
5.2.3 By Application - China Antisense and RNAi Therapeutics Revenue Market Share, 2016-2027
6 Antisense and RNAi Therapeutics Companies Profiles
6.1 Tekmira Pharmaceuticals
6.1.1 Tekmira Pharmaceuticals Company Details
6.1.2 Tekmira Pharmaceuticals Business Overview
6.1.3 Tekmira Pharmaceuticals Antisense and RNAi Therapeutics Introduction
6.1.4 Tekmira Pharmaceuticals Antisense and RNAi Therapeutics Revenue in China Market (2016-2021)
6.1.5 Tekmira Pharmaceuticals Recent Developments
6.2 Arbutus Biopharma
6.2.1 Arbutus Biopharma Company Details
6.2.2 Arbutus Biopharma Business Overview
6.2.3 Arbutus Biopharma Antisense and RNAi Therapeutics Introduction
6.2.4 Arbutus Biopharma Antisense and RNAi Therapeutics Revenue in China Market (2016-2021)
6.2.5 Arbutus Biopharma Recent Developments
6.3 Alnylam Pharmaceuticals
6.3.1 Alnylam Pharmaceuticals Company Details
6.3.2 Alnylam Pharmaceuticals Business Overview
6.3.3 Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Introduction
6.3.4 Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Revenue in China Market (2016-2021)
6.3.5 Alnylam Pharmaceuticals Recent Developments
6.4 Antisense Therapeutics
6.4.1 Antisense Therapeutics Company Details
6.4.2 Antisense Therapeutics Business Overview
6.4.3 Antisense Therapeutics Antisense and RNAi Therapeutics Introduction
6.4.4 Antisense Therapeutics Antisense and RNAi Therapeutics Revenue in China Market (2016-2021)
6.4.5 Antisense Therapeutics Recent Developments
6.5 Silence Therapeutics
6.5.1 Silence Therapeutics Company Details
6.5.2 Silence Therapeutics Business Overview
6.5.3 Silence Therapeutics Antisense and RNAi Therapeutics Introduction
6.5.4 Silence Therapeutics Antisense and RNAi Therapeutics Revenue in China Market (2016-2021)
6.5.5 Silence Therapeutics Recent Developments
6.6 Isis Pharmaceuticals
6.6.1 Isis Pharmaceuticals Company Details
6.6.2 Isis Pharmaceuticals Business Overview
6.6.3 Isis Pharmaceuticals Antisense and RNAi Therapeutics Introduction
6.6.4 Isis Pharmaceuticals Antisense and RNAi Therapeutics Revenue in China Market (2016-2021)
6.6.5 Isis Pharmaceuticals Recent Developments
6.7 Sirnaomics
6.7.1 Sirnaomics Company Details
6.7.2 Sirnaomics Business Overview
6.7.3 Sirnaomics Antisense and RNAi Therapeutics Introduction
6.7.4 Sirnaomics Antisense and RNAi Therapeutics Revenue in China Market (2016-2021)
6.7.5 Sirnaomics Recent Developments
6.8 Santaris
6.8.1 Santaris Company Details
6.8.2 Santaris Business Overview
6.8.3 Santaris Antisense and RNAi Therapeutics Introduction
6.8.4 Santaris Antisense and RNAi Therapeutics Revenue in China Market (2016-2021)
6.8.5 Santaris Recent Developments
6.9 Roche
6.9.1 Roche Company Details
6.9.2 Roche Business Overview
6.9.3 Roche Antisense and RNAi Therapeutics Introduction
6.9.4 Roche Antisense and RNAi Therapeutics Revenue in China Market (2016-2021)
6.9.5 Roche Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Tables
Table 1. Antisense and RNAi Therapeutics Market Opportunities & Trends in China Market
Table 2. Antisense and RNAi Therapeutics Market Drivers in China Market
Table 3. Antisense and RNAi Therapeutics Market Restraints in China Market
Table 4. Key Players of Antisense and RNAi Therapeutics in China Market
Table 5. Top Antisense and RNAi Therapeutics Players in China Market, Ranking by Revenue (2019)
Table 6. China Antisense and RNAi Therapeutics Revenue by Companies, (US$, Mn), 2016-2021
Table 7. China Antisense and RNAi Therapeutics Revenue Share by Companies, 2016-2021
Table 8. Companies Antisense and RNAi Therapeutics Product Type
Table 9. List of Tier 1 Antisense and RNAi Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Antisense and RNAi Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - China Antisense and RNAi Therapeutics Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - China Antisense and RNAi Therapeutics Revenue (US$, Mn), 2016-2021
Table 13. By Type - China Antisense and RNAi Therapeutics Revenue (US$, Mn), 2022-2027
Table 14. By Application - China Antisense and RNAi Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - China Antisense and RNAi Therapeutics Revenue (US$, Mn), 2016-2021
Table 16. By Application - China Antisense and RNAi Therapeutics Revenue (US$, Mn), 2022-2027
Table 17. Tekmira Pharmaceuticals Company Details
Table 18. Tekmira Pharmaceuticals Business Overview
Table 19. Tekmira Pharmaceuticals Antisense and RNAi Therapeutics Product
Table 20. Tekmira Pharmaceuticals Antisense and RNAi Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
Table 21. Tekmira Pharmaceuticals Recent Developments
Table 22. Arbutus Biopharma Company Details
Table 23. Arbutus Biopharma Business Overview
Table 24. Arbutus Biopharma Antisense and RNAi Therapeutics Product
Table 25. Arbutus Biopharma Antisense and RNAi Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
Table 26. Arbutus Biopharma Recent Developments
Table 27. Alnylam Pharmaceuticals Company Details
Table 28. Alnylam Pharmaceuticals Business Overview
Table 29. Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Product
Table 30. Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
Table 31. Alnylam Pharmaceuticals Recent Developments
Table 32. Antisense Therapeutics Company Details
Table 33. Antisense Therapeutics Business Overview
Table 34. Antisense Therapeutics Antisense and RNAi Therapeutics Product
Table 35. Antisense Therapeutics Antisense and RNAi Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
Table 36. Antisense Therapeutics Recent Developments
Table 37. Silence Therapeutics Company Details
Table 38. Silence Therapeutics Business Overview
Table 39. Silence Therapeutics Antisense and RNAi Therapeutics Product
Table 40. Silence Therapeutics Antisense and RNAi Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
Table 41. Silence Therapeutics Recent Developments
Table 42. Isis Pharmaceuticals Company Details
Table 43. Isis Pharmaceuticals Business Overview
Table 44. Isis Pharmaceuticals Antisense and RNAi Therapeutics Product
Table 45. Isis Pharmaceuticals Antisense and RNAi Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
Table 46. Isis Pharmaceuticals Recent Developments
Table 47. Sirnaomics Company Details
Table 48. Sirnaomics Business Overview
Table 49. Sirnaomics Antisense and RNAi Therapeutics Product
Table 50. Sirnaomics Antisense and RNAi Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
Table 51. Sirnaomics Recent Developments
Table 52. Santaris Company Details
Table 53. Santaris Business Overview
Table 54. Santaris Antisense and RNAi Therapeutics Product
Table 55. Santaris Antisense and RNAi Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
Table 56. Santaris Recent Developments
Table 57. Roche Company Details
Table 58. Roche Business Overview
Table 59. Roche Antisense and RNAi Therapeutics Product
Table 60. Roche Antisense and RNAi Therapeutics Revenue in China Market (2016-2021) & (US$ Million)
Table 61. Roche Recent Developments
List of Figures
Figure 1. Antisense and RNAi Therapeutics Segment by Type
Figure 2. Antisense and RNAi Therapeutics Segment by Application
Figure 3. China Antisense and RNAi Therapeutics Market Overview: 2020
Figure 4. China Antisense and RNAi Therapeutics Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. China Antisense and RNAi Therapeutics Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Antisense and RNAi Therapeutics Revenue in 2020
Figure 7. By Type - China Antisense and RNAi Therapeutics Revenue Market Share, 2016-2027
Figure 8. By Application - China Antisense and RNAi Therapeutics Revenue Market Share, 2016-2027
Figure 9. Tekmira Pharmaceuticals Antisense and RNAi Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Arbutus Biopharma Antisense and RNAi Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Alnylam Pharmaceuticals Antisense and RNAi Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Antisense Therapeutics Antisense and RNAi Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Silence Therapeutics Antisense and RNAi Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. Isis Pharmaceuticals Antisense and RNAi Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. Sirnaomics Antisense and RNAi Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. Santaris Antisense and RNAi Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. Roche Antisense and RNAi Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
  • Global Targeted RNA Sequencing Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 71
    Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing The ability to detect both known and novel gene fusion partners in many sample types. In The report, we ......
  • Global Targeted RNA Sequencing Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 87
    According to our LPI (LP Information) latest study, the global Targeted RNA Sequencing market size was valued at US$ 1761.4 million in 2023. With growing demand in downstream market, the Targeted RNA Sequencing is forecast to a readjusted size of US$ 7649.2 million by 2030 with a CAGR of 23.3% during review period. The research report highlights the growth potential of the global Targeted RNA Sequencing market. Targeted RNA Sequencing are expected to show stable growth in the future mark......
  • Global Targeted RNA Sequencing Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 94
    According to our (Global Info Research) latest study, the global Targeted RNA Sequencing market size was valued at USD 1852.7 million in 2023 and is forecast to a readjusted size of USD 7255.4 million by 2030 with a CAGR of 21.5% during review period. Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or ......
  • Global Antisense and RNAi Therapeutics Market Research Report 2023, Forecast to 2028
    Published: 26-Dec-2023        Price: US 2680 Onwards        Pages: 133
    Antisense therapy means the selective, sequence-specific inhibition of gene expression by single-stranded DNA oligonucleotides. In contrast, RNA interference (RNAi) is triggered by double-stranded RNA (dsRNA) and causes sequence-specific mRNA degradation of single-stranded target RNAs in response to dsRNA. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (millio......
  • Global Antisense and RNAi Therapeutics Professional Survey Report 2023, Forecast to 2028
    Published: 26-Dec-2023        Price: US 3280 Onwards        Pages: 101
    Antisense therapy means the selective, sequence-specific inhibition of gene expression by single-stranded DNA oligonucleotides. In contrast, RNA interference (RNAi) is triggered by double-stranded RNA (dsRNA) and causes sequence-specific mRNA degradation of single-stranded target RNAs in response to dsRNA. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (millio......
  • Global Targeted RNA Sequencing Market Research Report 2023, Forecast to 2028
    Published: 13-Nov-2023        Price: US 2680 Onwards        Pages: 137
    Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest.  Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product ......
  • Global Targeted RNA Sequencing Professional Survey Report 2023, Forecast to 2028
    Published: 13-Nov-2023        Price: US 3280 Onwards        Pages: 100
    Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest.  Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product ......
  • Global RNAi for Therapeutic Market Status and Outlook 2023-2028
    Published: 08-Nov-2023        Price: US 3160 Onwards        Pages: 106
    RNAi is a fundamental cellular mechanism for silencing gene expression that can be harnessed for the development of new drugs Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product ......
  • Global RNAi for Therapeutic Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 24-Oct-2023        Price: US 3380 Onwards        Pages: 104
    Market Overview of Global RNAi for Therapeutic market: According to our latest research, the global RNAi for Therapeutic market looks promising in the next 5 years. As of 2022, the global RNAi for Therapeutic market was estimated at USD 260.55 million, and it's anticipated to reach USD 3633.33 million in 2028, with a CAGR of 55.14% during the forecast years. RNA interference (RNAi) is a collection of small RNA directed mechanisms that result in sequence specific inhibition of......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs